RK

Radha Kantam Vemuri

Director Director DIN 03556927
DIN 03556927 First appointment Jul 2011 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2011
Shareholding value Locked Premium profile

About Radha Kantam Vemuri

Radha Kantam Vemuri has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Technology. Contributes to corporate operations.

DIN 03556927
Primary Designation Director
First Appointment 28 Jul 2011
Oldest Company Age 15 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Sirius Transtech Pharma Private Limited U72300TG2011PTC075712
Director 28 Jul 2011 2011 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sirius Transtech Pharma Private Limited
Premium access

Shareholding and investment profile for Radha Kantam Vemuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radha Kantam Vemuri

Radha Kantam Vemuri has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Technology. Contributes to corporate operations.

Radha Kantam Vemuri is associated with 0 companies as Director.

Radha Kantam Vemuri has expertise in Technology.

Radha Kantam Vemuri has 15 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available